These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8329786)

  • 1. Physical and chemical compatibility of intravenous ciprofloxacin with other drugs.
    Jim LK
    Ann Pharmacother; 1993 Jun; 27(6):704-7. PubMed ID: 8329786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility of ciprofloxacin injection with selected drugs and solutions.
    Goodwin SD; Nix DE; Heyd A; Wilton JH
    Am J Hosp Pharm; 1991 Oct; 48(10):2166-71. PubMed ID: 1781473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and chemical compatibility of drotrecogin alfa (activated) with 34 drugs during simulated Y-site administration.
    Mann HJ; Demmon SL; Boelk DA; Payne CA; Effron MB; Rajagopalan N; Williams MD; Beck GM; Gopalrathnam G
    Am J Health Syst Pharm; 2004 Dec; 61(24):2664-71. PubMed ID: 15646701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
    De Basagoiti A; Katsumiti A; Abascal S; Bustinza A; López-Giménez LR; Pascual P; De Miguel M; Campino A
    Eur J Pediatr; 2021 Apr; 180(4):1169-1176. PubMed ID: 33128625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability and compatibility of admixtures of intravenous ciprofloxacin and selected drugs.
    Elmore RL; Contois ME; Kelly J; Noe A; Poirier A
    Clin Ther; 1996; 18(2):246-55. PubMed ID: 8733985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion.
    Kambia NK; Luyckx M; Dine T; Dupin-Spriet T; Gressier B; Brunet C
    J Clin Pharm Ther; 2009 Feb; 34(1):25-31. PubMed ID: 19125900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The compatibility of a low concentration of hydrocortisone sodium succinate with selected drugs during a simulated Y-site administration.
    Semark AJ; Venkatesh K; McWhinney BC; Pretorius C; Roberts JA; Cohen J; Venkatesh B
    Crit Care Resusc; 2013 Mar; 15(1):63-6. PubMed ID: 23432505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical and chemical compatibility of daptomycin with nine medications.
    Lai JJ; Brodeur SK
    Ann Pharmacother; 2004 Oct; 38(10):1612-6. PubMed ID: 15328397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Y-site physical compatibility of hydrocortisone continuous infusions with admixtures used in critically ill patients.
    Foushee JA; Meredith P; Fox LM; Wilder AG
    Am J Health Syst Pharm; 2020 Jul; 77(14):1144-1148. PubMed ID: 32537625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures.
    Foushee JA; Meredith P; Fox LM; Grace E
    Int J Pharm Compd; 2016; 20(4):328-332. PubMed ID: 28333677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compatibility and stability of linezolid injection admixed with three quinolone antibiotics.
    Zhang Y; Xu QA; Trissel LA; Williams KY
    Ann Pharmacother; 2000 Sep; 34(9):996-1001. PubMed ID: 10981243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility of cefepime and vancomycin during simulated Y-site administration of prolonged infusion.
    Berti AD; Hutson PR; Schulz LT; Webb AP; Rose WE
    Am J Health Syst Pharm; 2015 Mar; 72(5):390-5. PubMed ID: 25694414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability and compatibility of fluorouracil and mannitol during simulated Y-site administration.
    Woloschuk DM; Wermeling JR; Pruemer JM
    Am J Hosp Pharm; 1991 Oct; 48(10):2158-60. PubMed ID: 1781472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compatibility and stability of paclitaxel combined with doxorubicin hydrochloride in infusion solutions.
    Trissel LA; Xu QA; Gilbert DL
    Ann Pharmacother; 1998 Oct; 32(10):1013-6. PubMed ID: 9793591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility of ketorolac tromethamine injection with common infusion fluids and administration sets.
    Floy BJ; Royko CG; Fleitman JS
    Am J Hosp Pharm; 1990 May; 47(5):1097-100. PubMed ID: 2337102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
    Trissel LA; Gilbert DL; Martinez JF; Baker MB; Walter WV; Mirtallo JM
    JPEN J Parenter Enteral Nutr; 1999; 23(2):67-74. PubMed ID: 10081995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
    Trissel LA; Saenz CA; Ogundele AB; Ingram DS
    Am J Health Syst Pharm; 2004 Nov; 61(21):2289-93. PubMed ID: 15552637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration.
    Mody V; Shah S; Patel J; Thomas MC
    Int J Pharm Compd; 2016; 20(3):236-238. PubMed ID: 28333664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
    Trissel LA; Williams KY; Gilbert DL
    J Am Pharm Assoc (Wash); 2000; 40(4):515-9. PubMed ID: 10932461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compatibility of ondansetron hydrochloride with meperidine hydrochloride for combined administration.
    Xu QA; Trissel LA; Fox JL
    Ann Pharmacother; 1995 Nov; 29(11):1106-9. PubMed ID: 8573953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.